DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Herbst RS, Baas P, Kim DW et al.
Pembrolizumab vs. docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.

Lancet 2015; pii: S0140-6736(15)01281-7 [Epub ahead of print]

Download Bibliographical Data

Search in: